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Careful history 
and thorough 
physical 
examination 
usually suggest 
the underlying 
cause of alopecia.
❚ Evidence summary
Our comprehensive literature search 
found no systematic reviews, random-
ized trials, or prospective cohort studies 
that answer this question. The differen-
tial diagnosis of clinical hair loss is large 
(TABLE). We reviewed indirect evidence 
and expert opinion to answer this Clini-
cal Inquiry.
Clues in the history
A detailed history—including medica-
Evidence-based answer
It’s unclear what the best approach is 
given the lack of studies on this issue. 
Indirect evidence and expert opinion 
indicate that a careful history and thorough 
physical examination usually suggest the 
underlying cause of alopecia. Ancillary 
laboratory evaluation and scalp biopsy 
are sometimes necessary to make 
or confi rm the diagnosis (strength of 
recommendation: C, expert opinion). 
Clinical commentary
Scarring or nonscarring, 
that’s the question
In my experience, evaluation of hair loss 
in women almost always fails to turn up a 
cause, and the alopecia typically resolves 
spontaneously within 6 to 12 months. I 
agree that the most useful investigations 
for ruling out specifi c etiologies are the 
history and physical examination. 
 The most important characteristic 
to evaluate is whether it is scarring or 
nonscarring. Scarring alopecia generally 
necessitates a biopsy. Identifying diffuse 
vs focal alopecia can further narrow the 
differential diagnosis. 
 The typical patient has diffuse, 
nonscarring hair loss in no defi ned pattern 
(central thinning suggestive of androgenic 
alopecia). Consider telogen effl uvium as 
the likely diagnosis. It can result from 
chronic illness, postpartum state, recent 
surgery/anesthesia, rapid weight loss, diet 
(iron defi ciency, vitamin A toxicity, 
and protein defi ciency), thyroid disease, 
or medications. Many commonly 
prescribed drugs can cause hair loss, 
including anticoagulants, nonsteroidal 
anti-infl ammatory drugs, β-blockers, 
H2 blockers, hormones, retinoids, and 
antihyperlipidemic agents. 
 Educating the patient, checking 
directed laboratory values occasionally, 
or modifying certain medications is often 
all that’s needed to reassure women 
with alopecia. Persistent, progressive 
scarring or patchy alopecia requires further 
investigation and possible dermatologic 
consultation. 
Robert Gauer, MD
University of North Carolina Faculty Development 
Fellowship 2006-2007, Fort Bragg 
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tion use, systemic illness, endocrine dys-
function, hair care practices, severe diet 
restriction, and family history—is key to 
establishing an accurate diagnosis of alo-
pecia.1 Other signifi cant considerations 
include the onset, duration, and pattern 
of hair loss; whether hair is broken or 
shed at the root; and whether shedding 
or thinning has increased.1,2 It’s also im-
portant to ascertain whether hair loss is 
limited to the scalp or affects other areas 
of the body. 
A family history of alopecia areata 
or androgenic alopecia can point to a 
genetic cause. Acne or abnormal menses 
can indicate androgen excess, suggesting 
androgenic alopecia. Positive answers to 
thyroid screening questions can point to 
hypothyroidism, and abnormal diet pat-
terns can suggest iron-defi ciency anemia. 
Unusual hair care practices can cause 
traction alopecia.1
3 stages of the physical exam
All hair-bearing sites should be exam-
ined. Clinical examination should be per-
formed in 3 stages:1,2 
•  Inspect the scalp for infl ammation, 
scale, and erythema to determine 
whether scarring is present. 
•  Examine the hair density and dis-
tribution pattern. 
•  Study the hair shaft quality, look-
ing at caliber, fragility, length, and 
shape. 
The “pull test” is often used to as-
sess ongoing hair loss. If more than 10% 
of hairs are pulled away from the scalp, 
the test is positive, suggesting active hair 
shedding.1 
Beyond the history and physical
Ancillary laboratory evaluation is some-
times necessary if the diagnosis remains 
unclear.1,2 Serum ferritin or a com-
plete blood count can be useful to look 
for iron-defi ciency anemia; a thyroid-
stimulating hormone test can rule out 
hypothyroidism.3 According to 1 small 
study of 50 women with diffuse alopecia, 
thyroid tests are not routinely warranted 
without supportive clinical signs.4 
Check free testosterone, androstene-
dione, and dehydroepiandrosterone if 
virilizing signs are present, to assess 
hyperandrogenism.1,3 Serum prolactin 
can be useful if the patient has galactor-
rhea.5 Also, consider a Venereal Disease 
Research Laboratory test to rule out 
syphilis.2,6 
No evidence suggests that low serum 
zinc concentrations cause hair loss. In 
fact, excessive intake of nutritional sup-
plements may lead to hair loss and aren’t 
recommended in the absence of a proven 
defi ciency.7 
Scarring alopecia 
almost always 
necessitates a 
biopsy.
Causes of nonscarring alopecia
COMMON LESS COMMON
Alopecia areata
Androgenetic alopecia
Drugs and other chemicals
Telogen effl uvium (both acute and chronic)
Tinea capitis
Traction alopecia
Human immunodefi ciency virus
Hyperthyroidism
Hypothyroidism
Iron defi ciency
Nutritional defi ciencies
Other systemic diseases
Secondary syphilis
Systemic lupus erythematosus
Trichotillomania
Adapted from: Habif TP. Clinical Dermatology. A Color Guide to Diagnosis and Therapy. 4th ed. 
Edinburgh: Mosby; 2004:838-842. 
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If a patient has scarring alopecia, a 
scalp biopsy is almost always necessary 
to make a diagnosis.1 Usually a punch 
biopsy is suffi cient, but it should be no 
smaller than 4 mm. The preferred loca-
tion is the central scalp in an area repre-
sentative of the hair loss.1,5
Recommendations
The University of Texas Family Nurse 
Practitioner Program recommends a 
thorough history and physical examina-
tion and, if indicated, selected laboratory 
evaluation.6 The program states that the 
Women’s Androgenetic Alopecia Qual-
ity of Life (WAA-QOL) Questionnaire is 
useful in evaluating health-related quality 
of life specifi c to women. 
The American Hair Loss Association 
recommends checking some screening 
labs on women with hair loss, but states 
that the diagnosis is usually a process of 
elimination as many of the laboratory 
tests mentioned above will come back in 
the normal range.8 ■
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